524636 — Oxygenta Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.13bn
- IN₹1.70bn
- IN₹396.42m
Annual cashflow statement for Oxygenta Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -59.4 | 31.4 | -4.89 | -114 | -139 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 10.7 | 17.6 | 9.2 | 14.8 | 16.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.3 | -75.1 | -35.8 | 64 | -34.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -25.9 | -16.2 | -16.8 | -16.3 | -130 |
| Capital Expenditures | -5.2 | -67.4 | -49.5 | -96.4 | -41.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.237 | 0.225 | 0.045 | 0.05 | 0.179 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.96 | -67.2 | -49.4 | -96.4 | -40.9 |
| Financing Cash Flow Items | -10.9 | -17.8 | -9.25 | -14.9 | -10.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.9 | 86.7 | 63.3 | 112 | 171 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.997 | 3.27 | -2.89 | -0.495 | -0.054 |